معرفی
Huanlian (Lian) Chen, M.S., served as a Former Research Scientist at the Lab for Mitochondrial Biology and Metabolic Dysfunction in Neurodegeneration within the Burke Neurological Institute. Affiliated with Weill Cornell Medicine, their research focused on mitochondrial dysfunction and protein modifications in neurodegenerative diseases, particularly Alzheimer’s disease. Key areas included proteomic analyses of acetylation/succinylation and clinical trial investigations.
Education: Master of Science (M.S.).
Research Interests: Chen’s work explored how mitochondrial protein modifications (e.g., acetylation, succinylation) contribute to neurodegenerative processes. They investigated biomarkers linked to Alzheimer’s pathology and evaluated therapeutic interventions like benfotiamine in clinical settings. Their studies combined proteomics, biochemistry, and clinical trial designs to advance understanding of disease mechanisms and potential treatments.
Publications: Chen contributed to high-impact studies on Alzheimer’s disease mechanisms, including proteomic changes in brain tissue and clinical trial outcomes. Their work bridges basic science and translational research, emphasizing mitochondrial dysfunction’s role in neurodegeneration.
Grants & Advising: While no formal advisees are listed, Chen collaborated on grant-funded projects exploring Alzheimer’s therapies and biomarkers. Contributions included data analysis and experimental design in multidisciplinary teams.
Labs & Teams: Core member of the Gibson Lab, focusing on mitochondrial biology and neurodegenerative diseases. Collaborated with institutions like Einstein College of Medicine and Montefiore Health System.
